Prescribing by pharmacists in a collaborative manner has been occurring in the UK for several years. There are minimal studies involving pharmacist prescribing in Australia. In the present audit, 34 medication charts (17 each from the pharmacist prescriber and medical officer) were reviewed for safety and accuracy. Medication charts written by a pharmacist were more accurate than those written by a medical officer when compared to the medication history. Discrepancies and omissions had more potential for patient harm in the charts written by the medical officer. In all, 146 orders prescribed by pharmacists and 145 orders prescribed by medical officers were reviewed for safety. Of these, 90% of orders written by the pharmacist were error free, compared with 26% written by medical officers. The incorporation of pharmacist prescribers into the admissions process has the potential to improve patient safety and decrease medication errors.
INTRODUCTION
Non-medical prescribing has gained an increased focus in recent years due, in part, to a shortage of healthcare resources.
1,2 Pharmacists, with their extensive training in pharmacology and therapeutics, may be particularly well-placed to act as non-medical prescribers. Hospital pharmacists have experience in practicing as part of a multidisciplinary team, which may prove useful in developing new models of pharmacist prescribing in Australia. Admission to hospital is a time of high risk for medication error. It has been demonstrated that medication errors most commonly occur at the time of prescribing and frequently occur on the day of hospital admission. 3, 4 Research has shown between 38% and 54% of patients had at least one unintended medication discrepancy between the patient's regular medication and the admission orders. [5] [6] [7] Evidence suggests that pharmacists take the most accurate medication histories, and clinical pharmacists in the emergency department (ED) can assist in identifying and preventing medication errors early in the hospital presentation. [8] [9] [10] This project used a collaborative, or supplementary, prescribing model. In this model, diagnosis and prescribing of new therapies remains the responsibility of the medical officer. [11] [12] [13] Supplementary prescribing by pharmacists has been studied in the US and UK, and has become common practice in many facilities across the UK. [14] [15] [16] [17] Investigation and assessment of the collaborative pharmacist prescribing model in an ED and admissions unit is a relatively unique initiative for the Australian setting. The present study builds on previous studies in Queensland of doctor-pharmacist collaborative prescribing in an elective surgery preadmission clinic and a sexual health outpatient clinic. 18, 19 Studies conducted in the UK have shown promising results with reduced discrepancies and improved patient safety when pharmacists transcribe the medication history onto the medication chart. 20 More recently, a study from Melbourne demonstrated a significant reduction in medication errors when pharmacists prescribed in a collaborative model. 21 
METHODS
For the purposes of this, and any ongoing, collaborative prescribing study, prescribing pharmacists have undertaken the Queensland University of Technology (QUT) Prescribing Course for Allied Health Professionals.
The setting of the present audit was a 630-bed major tertiary referral hospital located within the Metro North Hospital and Health Service, Queensland. The ED saw more than 80 000 attendances in 2016. The focus was on patients being admitted to the hospital from the ED under the care of a general medicine team. For the purposes of the present audit, prescribing was reviewed retrospectively. Only those patients presenting to hospital between 0800 and 1600 hours were included in the study to reflect usual pharmacist working hours. The pharmacist would act as prescriber opportunistically, where the patient had not yet been admitted by the medical team and did not have his or her usual medicines charted. The pharmacist prescriber charted only those medicines the patient was taking prior to admission, and were appropriate to continue, after discussion with the admitting medical officer. No new medicines were charted by the pharmacist prescriber.
Where the pharmacist acted as prescriber, a pharmacist completed the medication history as is usual practice, documented on a medication action plan (MAP) as per The Society of Hospital Pharmacists of Australia (SHPA) guidelines (https://www.shpa.org.au/resources/ standards-of-practice-for-clinical-pharmacy-services; accessed 1 September 2017). The prescribing pharmacist then collated recommendations on continuation, withholding or ceasing usual medicines. The medication history and recommendations were then discussed with the admitting medical officer to agree on a medication plan. The prescribing pharmacist then prescribed the plan onto a national inpatient medication chart (NIMC), with a record of their discussion with the admitting medical officer recorded in the medical notes. The medical officer then countersigned all orders prescribed by the pharmacist. Medication charts were reviewed by the usual ward pharmacist, as is usual practice, to perform medication reconciliation.
Where the medical officer acted as prescriber, the medication history was taken by a pharmacist and recorded on a MAP form either before or after the medication chart of ongoing medicines had been completed, reflecting usual practice. The timing of MAP completion with regard to the medication chart being prescribed was recorded. The responsibility of prescribing the medication chart was with the admitting medical officer, as is usual practice.
A final year pharmacy student assisted with data collection. Medication charts and MAP forms from both arms were evaluated retrospectively to assess the accuracy of the medications prescribed against the medication history. Patient notes were used to establish whether omissions or dose changes were intentional. Where dose changes or omissions were unintentional, the severity of potential harm was assessed using a risk matrix that considered consequences and likelihood of patient harm.
Prescription orders were also evaluated retrospectively, using an established NIMC audit tool to assess safety and completeness of orders. 22 An 'error-free'
order rate was calculated for comparison with hospital key performance indicators. For an order to be considered error free, it must have been clear and correct with regard to medication name, dose, frequency, route of administration and contain no unacceptable abbreviations. 23 In addition, PRN orders required a maximum dose and hourly frequency to be considered error free. All errors or omissions in the accuracy and safety of medication charts were reviewed by a local review panel of medical and pharmacy staff to determine their level of significance.
RESULTS
Medication charts from 17 patients with collaborative pharmacist-prescribed charts and 17 patients with medical officer-prescribed charts were reviewed. This equated to 146 medical orders written by a pharmacist and 145 medication orders written by a medical officer. In the groups with pharmacist-and medical officer-prescribed charts, mean patient age was 78 and 73 years, respectively, with 59% and 56% of patients in these two groups, respectively, being female. Medication charts had been written between June and October 2016 and were collected as a convenience sample due to the limited availability of medical records.
When reviewing the MAP forms for each patient, there were three errors identified by ward pharmacists in the pharmacist prescriber group (2% chance of error per medication order) and 23 errors identified by pharmacists in the medical officer prescriber group (16% chance of error per medication order). In the pharmacist-prescribed charts, one error was considered to have high potential for patient harm (<1% chance of medium-very high risk error per medication order), whereas the other two issues were deemed low risk. In the medical officer-prescribed charts, 15 of 23 orders (65%) were considered to have a medium, high or very high risk of patient harm (10% chance of medium-very high risk error per medication order). Interestingly, for half the MAP issues relating to medical officer-prescribed charts, the medication history was completed by a pharmacist prior to the medical officer prescribing.
When assessed using the NIMC audit tool, 90% of medication orders written by the pharmacist were considered error free. The error-free medication order rate for medical officers was 26%, in line with recent independent audits.
DISCUSSION
Medication charts written by a collaborative pharmacist prescriber were more likely to be accurate against the medication history than those written by a medical officer prescriber (2% vs 16% chance of error per medication order). Errors found in the pharmacist prescriber group were less likely to be medium-very high risk than those found in the medical officer prescriber group (<1% vs 10%). When audited for safety, medications were more likely to be prescribed appropriately in the pharmacistprescribed charts than in the medical officer-prescribed charts (90% vs 26%).
CONCLUSION
Pharmacist prescribing is in the early stages of practice in the Australian setting. The present small study demonstrates that pharmacist prescribing of regular medicines for general medical patients is safer and more accurate than medical officer prescribing.
